Virginia Tech® home

From FBRI to NIH: Charting a Path Out of the Lab to Science Planning and Policy

Insert your title here

Alicia Kerr, Ph.D.

Health Science Policy Analyst
Office of Program Planning and Analysis
National Eye Institute
National Institutes of Health

From FBRI to NIH: Charting a Path Out of the Lab to Science Planning and Policy

Date: May 14, 2024

Time:  11 a.m.

About this Seminar

In her return to the Fralin Biomedical Research Institute at VTC, Dr. Kerr will discuss her path to becoming a health science policy analyst at the National Eye Institute, part of the National Institutes of Health (NIH). She is an alumnus of the Translational Biology, Medicine, and Health graduate program, the research institute’s Center for Neurobiology Research, and the Fox Lab. Her talk will include insights into the structure of NIH, Congressional appropriations, program planning, and how to get your foot in the door to a scientific career in the Federal Government. 

You May Also Be Interested In...

  • Home Item
    The Role of Exercise in Memory Function
    The Role of Exercise in Memory Function , home

    May 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute

  • Home Item
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , home

    May 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    Targeting Acquired Dependencies During Tumor Evolution
    Targeting Acquired Dependencies During Tumor Evolution , home

    June 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.